Premarket Clinical Safety Assessment of the ELISIO™-HX

Clinical trial NCT07058909 · COMPLETED

Trial details

NCT number: NCT07058909
Sponsor: Nipro Medical Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Renal Failure Acute Renal Failure Chronic Renal Failure Chronic Kidney Diseases End Stage Renal Disease

Start date: 2025-09-08
Primary completion: 2026-02-25
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.